Characterizing clinical phenotypes: The Lewys in their life or the life of their Lewys?

Neurology

Volumn 67, Issue 11, 2006, Pages 1910-1911

  Lippa, Carol F ^a   Emre, Murat ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CHOLINESTERASE INHIBITOR;

CHOLINERGIC ACTIVITY; CORRELATION ANALYSIS; DEMENTIA; DISEASE DURATION; EDITORIAL; HUMAN; LEWY BODY; MEYNERT BASAL NUCLEUS; MOTOR DYSFUNCTION; NEUROPATHOLOGY; PARKINSONISM; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODY DISEASE; PARKINSON DISEASE; PHENOTYPE;

EID: 33845701691     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000250234.72903.37     Document Type: Editorial

References (9)

1. Ballard C, Ziabreva I, Perry R, et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006;67:1931-1934.
2. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994;5:747-749.
3. Lippa CF, Smith TW, Perry E. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 1999;106:525-535.
4. Perry EK, McKeith I, Thompson P, et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202.
5. Hurtig HI, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-1921.
6. Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003;300:636-640.
7. Lippa SM, Lippa CF, Mori H. Alpha-synuclein aggregation in pathological aging and Alzheimer's disease: the impact of beta-amyloid plaque level. Am J Alzheimers Dis Other Demen 2005;20:315-318.
8. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
9. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD Working Group Symposium: boundary issues and future priorities. (In revision).